News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,827 Results
Type
Article (40434)
Company Profile (266)
Press Release (666126)
Multimedia
Podcasts (61)
Webinars (14)
Section
Business (204760)
Career Advice (2011)
Deals (35536)
Drug Delivery (96)
Drug Development (81480)
Employer Resources (172)
FDA (16297)
Job Trends (14910)
News (346379)
Policy (32657)
Tag
Academia (2563)
Accelerated approval (9)
Adcomms (22)
Allergies (96)
Alliances (49729)
ALS (108)
Alzheimer's disease (1442)
Antibody-drug conjugate (ADC) (154)
Approvals (16289)
Artificial intelligence (311)
Autoimmune disease (35)
Automation (18)
Bankruptcy (361)
Best Places to Work (11655)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (190)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (365)
Cancer (2869)
Cardiovascular disease (212)
Career advice (1682)
Career pathing (30)
CAR-T (191)
CDC (30)
Cell therapy (509)
Cervical cancer (22)
Clinical research (67115)
Collaboration (1019)
Company closure (3)
Compensation (686)
Complete response letters (23)
COVID-19 (2632)
CRISPR (57)
C-suite (325)
Cystic fibrosis (112)
Data (3002)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (347)
Diagnostics (6434)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (139)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87571)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (114140)
Executive appointments (849)
FDA (17944)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (936)
Gene editing (131)
Generative AI (22)
Gene therapy (375)
GLP-1 (781)
Government (4513)
Grass and pollen (4)
Guidances (181)
Healthcare (18902)
HIV (40)
Huntington's disease (30)
IgA nephropathy (40)
Immunology and inflammation (156)
Immuno-oncology (8)
Indications (39)
Infectious disease (2804)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (312)
IPO (16628)
IRA (44)
Job creations (3643)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (494)
Leadership (19)
Legal (7934)
Liver cancer (79)
Longevity (11)
Lung cancer (399)
Lymphoma (210)
Machine learning (11)
Management (58)
Manufacturing (385)
MASH (92)
Medical device (13463)
Medtech (13468)
Mergers & acquisitions (19626)
Metabolic disorders (850)
Multiple sclerosis (99)
NASH (17)
Neurodegenerative disease (114)
Neuropsychiatric disorders (33)
Neuroscience (2120)
NextGen: Class of 2025 (6547)
Non-profit (4494)
Now hiring (47)
Obesity (427)
Opinion (221)
Ovarian cancer (101)
Pain (105)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (296)
Patient recruitment (165)
Peanut (51)
People (57833)
Pharmaceutical (65)
Pharmacy benefit managers (21)
Phase I (20911)
Phase II (29596)
Phase III (21972)
Pipeline (1635)
Policy (199)
Postmarket research (2568)
Preclinical (8919)
Press Release (64)
Prostate cancer (140)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (460)
Real estate (5928)
Recruiting (66)
Regulatory (22678)
Reports (50)
Research institute (2350)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (159)
Series B (110)
Service/supplier (11)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3617)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (39)
Vaccines (779)
Venture capital (54)
Weight loss (256)
Women's health (47)
Worklife (16)
Date
Today (64)
Last 7 days (361)
Last 30 days (1881)
Last 365 days (31345)
2025 (16813)
2024 (35365)
2023 (40177)
2022 (51318)
2021 (55887)
2020 (54236)
2019 (46656)
2018 (35102)
2017 (32199)
2016 (31596)
2015 (37655)
2014 (31392)
2013 (26431)
2012 (28648)
2011 (29348)
2010 (27413)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38425)
Australia (6277)
California (7452)
Canada (2358)
China (679)
Colorado (320)
Connecticut (318)
Delaware (192)
Europe (82877)
Florida (1116)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (640)
India (27)
Indiana (361)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1026)
Massachusetts (5547)
Michigan (246)
Minnesota (450)
Mississippi (3)
Missouri (90)
Montana (31)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2075)
New Mexico (28)
New York (2084)
North Carolina (1082)
North Dakota (8)
Northern California (3276)
Ohio (235)
Oklahoma (16)
Oregon (37)
Pennsylvania (1615)
Puerto Rico (17)
Rhode Island (36)
South America (1103)
South Carolina (34)
South Dakota (1)
Southern California (2782)
Tennessee (126)
Texas (1124)
United States (27618)
Utah (219)
Virginia (185)
Washington D.C. (72)
Washington State (641)
West Virginia (4)
Wisconsin (66)
706,827 Results for "autoimmune inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Autoimmune disease
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put Cullinan in a better position to target autoimmune diseases.
June 5, 2025
·
2 min read
·
Tristan Manalac
Cell therapy
5 CAR T Cell Therapies With Autoimmune Readouts in 2025
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune disorders, with several early- to mid-stage readouts expected this year.
March 17, 2025
·
9 min read
·
Tristan Manalac
Immunology and inflammation
Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition
Novartis is falling farther behind AbbVie, which expanded its JAK inhibitor Rinvoq into giant cell arteritis in April.
July 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
June 24, 2025
·
5 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
·
7 min read
Press Releases
Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases
June 13, 2025
·
2 min read
Press Releases
Candid Therapeutics Advances Portfolio of Novel T-Cell Engagers into Five Autoimmune Diseases for Clinical Evaluation
June 20, 2025
·
4 min read
Press Releases
Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP)
May 27, 2025
·
6 min read
Press Releases
iPSC-CAR-NK Cell Therapy Clinical Result Published in Cell, Marking a Global Breakthrough in Autoimmune Disease Treatment
June 26, 2025
·
4 min read
Press Releases
AbelZeta Presents New Data on C-CAR168 for the Treatment of Autoimmune Diseases at LUPUS 2025
May 23, 2025
·
5 min read
1 of 70,683
Next
